MentionFox
Home › funding signals › Triomics
Accelerator · announced

Triomics (YC W21) — AI agents for oncology EHRs

Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting.

Triomics is a Y Combinator company in the Winter 2021 batch. Its directory entry describes it as: AI Agents for Oncology EHRs. The founders listed are Sarim Khan (Founder), Hrituraj Singh (Founder) (Y Combinator directory entry, March 2, 2021).

6 more companies from YC Winter 2021 ↓

Run the free check on Triomics →

Sell to companies like Triomics? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Triomics

New accelerator entry · 2021-03-02 · the record

Winter 2021
batch
50
people
Growth
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2021
Announced2021-03-02
StageGrowth
StatusActive
Team size50
IndustryHealthcare
Sub-industryHealthcare -> Healthcare Services
SectorsHealthcare, Healthcare IT
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedNew York City, NY, USA
HiringYes
Sitehttps://triomics.com/
Founded2021
YC group partnerJared Friedman
Previously known asTriomics Healthcare Private Limited

Pitching, partnering or investing alongside them? See who really runs and owns Triomics.

Free to see. No signup.

Keep reading

More on Triomics and the records around it.

Also in YC Winter 2021

Same batch, Healthcare first.

What do you want to do with Triomics?

Get the full cited report on Triomics

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Triomics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting. We replace that manual work with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time.S. News, as well as several of the largest community oncology practices.

Want the whole picture on Triomics?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Triomics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Triomics covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Triomics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Triomics. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Triomics: Accepted into Y Combinator Winter 2021
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-triomics
Last updated 2026-10-29
Primary record: Y Combinator directory entry
Triomics (YC W21) — AI agents for oncology EHRs. MentionFox, 2026-10-29. https://mentionfox.com/funding/yc-triomics